Pan Li

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Nan Niu · 3 shared papers, 2022–2023 · strength 0.37
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
2. Junke Wang · 3 shared papers, 2022–2023 · strength 0.37
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
3. Lei Zheng · 3 shared papers, 2022–2023 · strength 0.37
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
4. Yao Xu · 2 shared papers, 2022–2023 · strength 0.25
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
5. Keyu Li · 2 shared papers, 2022 · strength 0.24
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
6. Arsen Osipov · 2 shared papers, 2022 · strength 0.24
   • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
   • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
7. William Reece Burns · 1 shared paper, 2023 · strength 0.13
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
8. Noelle R. Jurcak · 1 shared paper, 2023 · strength 0.13
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
9. Sophia Y. Chen · 1 shared paper, 2023 · strength 0.13
   • Paper CLDN18.2 BiTE Engages Effector and Regulatory T Cells for Antitumor Immune Response in Preclinical Models of Pancreatic… DOI 10.1053/j.gastro.2023.06.037↗
10. Jianxin Wang · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
11. Brian T. Herbst · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
12. Stephen T. Muth · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
13. Noah S Rozich · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
14. Barish H. Edil · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
15. Tingbo Liang · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
16. Christopher L. Wolfgang · 1 shared paper, 2022 · strength 0.12
    • Paper Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humaniz… DOI 10.1016/j.canlet.2022.215722↗
17. Andrew Eugene Hendifar · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
18. Jianxin Wang · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
19. Richard Andrew Burkhart · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
20. Jun Gong · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
21. Stephen Jacob Pandol · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗
22. Alex B. Blair · 1 shared paper, 2022 · strength 0.12
    • Paper Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy. DOI 10.1053/j.gastro.2022.06.027↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.